| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.207 | 7.474 | 8.235 | 9.658 | 878 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 1.207 | 7.474 | 8.235 | 9.658 | 878 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 2.885 | 8.168 | 8.364 | 3.618 | 1.015 | 345 | 556 | 184 | 588 |
| Gross Profit/Loss - EUR | - | -1.678 | -695 | -129 | 6.040 | -138 | -345 | -556 | -184 | -588 |
| Net Profit/Loss - EUR | - | -1.702 | -826 | -211 | 5.751 | -158 | -345 | -556 | -184 | -588 |
| Employees | - | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Original By Rovirex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 535 | 434 | 336 | 241 | 0 | 0 | 0 |
| Current Assets | - | 370 | 215 | 850 | 6.183 | 6.090 | 5.834 | 3.868 | 1.813 | 1.598 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 109 | 186 | 370 | 0 | 0 | 0 | 0 | 29 |
| Cash | - | 370 | 105 | 663 | 5.813 | 6.090 | 5.834 | 3.868 | 1.813 | 1.569 |
| Shareholders Funds | - | -1.658 | -2.456 | -2.622 | 3.180 | 2.961 | 2.551 | 2.002 | 1.813 | 1.327 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.028 | 2.670 | 4.028 | 3.437 | 3.465 | 3.524 | 1.866 | 0 | 271 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9622 - 9622" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Original By Rovirex Srl